Literature DB >> 9202326

An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.

W Maruyama1, M Naoi, T Kasamatsu, Y Hashizume, T Takahashi, K Kohda, P Dostert.   

Abstract

Recently, an endogenous neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline [N-methyl-(R)-salsolinol], was found to elicit parkinsonism in rats with selective depletion of dopamine neurons in the substantia nigra without necrotic tissue reaction. The mechanism of the cell death was examined by detection of DNA damage using a single-cell gel electrophoresis (comet) assay in human dopaminergic neuroblastoma SH-SY5Y cells. Only N-methylsalsolinol was found to induce DNA damage, whereas other catechol isoquinolines, such as (R)-salsolinol, (S)-salsolinol, and 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, did not. The (R)-enantiomer of N-methylsalsolinol damaged DNA much more profoundly than the (S)-enantiomer. Cycloheximide protected the cells from DNA damage, suggesting that an apoptotic process may account for the DNA damage. Morphological changes indicating apoptotic cell death were also confirmed. Antioxidants and deprenyl reduced DNA damage, indicating that the damage was initiated by oxidative stress and that neuroprotection by deprenyl may be partially ascribed to its prevention of DNA damage. Apoptosis induced by neurotoxins may be a mechanism underlying the cell death of dopamine neurons in the substantia nigra of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202326     DOI: 10.1046/j.1471-4159.1997.69010322.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Hydrogen peroxide-induced neurotoxicity in cultured cortical cells grown in serum-free and serum-containing media.

Authors:  K C Ricart; M L Fiszman
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

3.  Chiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: observation of complex stereoisomerism.

Authors:  Hao Wu; Baiqing Yuan; Yi-Ming Liu
Journal:  J Chromatogr A       Date:  2011-03-21       Impact factor: 4.759

Review 4.  The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.

Authors:  Zixuan Chen; Madiha Rasheed; Yulin Deng
Journal:  Brain Pathol       Date:  2021-08-20       Impact factor: 7.611

5.  Inhibitory effects of lysophosphatidylcholine on the dopaminergic system.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Kennie R Shepherd; Nazarius S Lamango; Karam F A Soliman; Clivel G Charlton
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

6.  Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.

Authors:  Orly Weinreb; Tamar Amit; Yotam Sagi; Noam Drigues; Moussa B H Youdim
Journal:  J Neural Transm (Vienna)       Date:  2009-04-25       Impact factor: 3.575

7.  Computational Modeling of Inclusion Complexes of β-Cyclodextrin with enantiomers of Salsolinol, N-Methyl-Salsolinol, and 1-Benzyl-Tetrahydroisoquinoline.

Authors:  Ming-Ju Huang; Zhe Quan; Yi-Ming Liu
Journal:  Int J Quantum Chem       Date:  2009       Impact factor: 2.444

8.  Anti-apoptotic function of propargylamine inhibitors of type-B monoamine oxidase.

Authors:  M Naoi; W Maruyama; M B H Youdim; P Yu; A A Boulton
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

9.  Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2015-02-25       Impact factor: 3.911

Review 10.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.